| Name | Title | Contact Details |
|---|
CSL Behring is a biopharmaceutical company, manufacturing plasma-derived and recombinant therapeutic products and providing them to people in more than 100 countries.
Channel Medsystems is a venture-backed company that was founded to bring innovation to the delivery of women’s healthcare. We strive to develop treatments to meet the unique needs of female patients and the high standards of their healthcare providers. We are committed to ensuring that patients have access to high quality outcomes that can be delivered in the convenience and comfort of their healthcare providers office.
AO North America is a Paoli, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
We are a biopharmaceutical company developing first-in-class therapies for cancer. Imetelstat, a novel, first-in-class telomerase inhibitor, is our product candidate in clinical development. Telomerase enables cancer cells to maintain telomere length, which provides them with the capacity for limitless cellular replication. Imetelstat is a potent and specific inhibitor of telomerase. Based on clinical data we obtained in late 2012, we may develop imetelstat to treat one or more hematologic myeloid malignancies such as myelofibrosis, or MF, myelodysplastic syndromes, or acute myelogenous leukemia.
Established as a non-profit organization in 1995, the Upper Chesapeake Health Foundation is dedicated to supporting UCH and its vision to create the healthiest community in Maryland. The funds raised are managed in accordance with donor wishes,